Pain Assessment in patients undergoing neurosurgery
Recruiting
- Conditions
- Acute pain, not elsewhere classified, (2) ICD-10 Condition: G892||Chronic pain, not elsewhere classified,
- Registration Number
- CTRI/2021/09/036525
- Lead Sponsor
- NIMHANS
- Brief Summary
In this study, we will be evaluating the incidence of acute and chronic pain after neurosurgery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
All neurosurgical patients aged 18 and above.
Exclusion Criteria
We will exclude children, patients with GCS < 15, patients not extubated within 2 hours of end of anesthesia and those who not able to respond to our questions on outcomes.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence and severity of postoperative pain Immediate postoperative period
- Secondary Outcome Measures
Name Time Method Persistent postoperative pain and impact of activities of daily living, medication needs, sleep, return to work 3 and 6 months after surgery Nociception level by objective parameter intraoperative period Risk factors for postoperative pain pre, intra and immediate postoperative period Impact of acute postoperative pain - sleep, hospital stay, satisfaction, time to ambulate postoperative period
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie acute and chronic pain development after neurosurgery in CTRI/2021/09/036525?
How does the incidence of post-neurosurgery pain in CTRI/2021/09/036525 compare to standard-of-care outcomes in similar patient cohorts?
Are there specific biomarkers identified in CTRI/2021/09/036525 that correlate with risk factors for significant postoperative pain in neurosurgery patients?
What are the potential adverse events associated with neurosurgical procedures in CTRI/2021/09/036525 and how are they managed?
How do combination analgesic strategies compare to monotherapies in managing post-neurosurgery pain as studied in CTRI/2021/09/036525?
Trial Locations
- Locations (1)
Neurocenter building
🇮🇳Bangalore, KARNATAKA, India
Neurocenter building🇮🇳Bangalore, KARNATAKA, IndiaDr SriganeshPrincipal investigator09481445949drsri23@gmail.com